HKU4-HR2P1 (1247-1282)

General Information


DRACP ID  DRACP03988

Peptide Name   HKU4-HR2P1 (1247-1282)

Sequence  GPNFAEISKINTTLLDLSDEMAMLQEVVKQLNDSYI

Sequence Length  36

UniProt ID  A3EX94 

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antiviral



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C177H287N43O60S2

Absent amino acids  CHRW

Common amino acids  L

Mass  466609

Pl  3.82

Basic residues  2

Acidic residues  6

Hydrophobic residues  13

Net charge  -4

Boman Index  -4449

Hydrophobicity  -6.39

Aliphatic Index  108.33

Half Life 
  Mammalian: 1.9 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  1490

Absorbance 280nm  42.57

Polar residues  10

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 30646495

Title  Potent MERS-CoV Fusion Inhibitory Peptides Identified From HR2 Domain in Spike Protein of Bat Coronavirus HKU4

Doi Not available

Year  2019

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  15181

DRACP is developed by Dr.Zheng's team.